In a panel discussion held at WMS 2020, experts in the field of gene therapy for neuromuscular disorders (NMDs) discussed dosing and safety issues for novel gene-based therapies.
The key points of the discussion included:
In a panel discussion held at WMS 2020, experts in the field of gene therapy for neuromuscular disorders (NMDs) discussed dosing and safety issues for novel gene-based therapies.
The key points of the discussion included: